Form 4: Intuitive Surgical EVP Jamie Samath Executes Stock Options and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
EVP & CFO of Intuitive Surgical, Jamie Samath, reports exercising stock options and selling shares under a pre-arranged 10b5-1 trading plan.
Summary
- Jamie Samath, EVP & CFO of Intuitive Surgical, executed stock options and sold shares of common stock on February 10, 2025.
- These transactions were conducted under a pre-arranged trading plan that complies with SEC Rule 10b5-1, set to expire on May 6, 2025.
- Samath exercised options to acquire 135 shares at $229.39 and 134 shares at $304.67.
- He also exercised 1,078 Restricted Stock Units (RSUs).
- A total of 269 shares were sold at $590.
- After these transactions, Samath directly owns 3,282 shares of common stock.
- He also holds options for 3,232 shares at exercise prices of $229.39 and $304.67, respectively, and 2,154 RSUs.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The transactions are part of a pre-planned trading strategy and do not necessarily indicate a change in the executive's outlook on the company.
Positives
- The transactions were conducted under a pre-arranged 10b5-1 trading plan, indicating a planned and transparent approach to stock transactions.
Future Outlook
The reporting person will continue to execute transactions under the 10b5-1 trading plan until its expiration on May 6, 2025.
Industry Context
Executive stock transactions are common in publicly traded companies and are often scrutinized by investors for insights into management's perspective on the company's future performance. The use of a 10b5-1 plan provides a structured and transparent framework for these transactions.
Comparison to Industry Standards
- Executive compensation practices, including stock options and RSUs, are standard across the medical device industry.
- Companies like Stryker (SYK) and Medtronic (MDT) also utilize similar equity-based compensation to align executive interests with shareholder value.
- The vesting schedules and terms of these equity grants are generally comparable to industry norms.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increase in the number of shares available in the market.
- The transactions do not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 02/10/2023 | Initial vesting date for RSUs and stock options. |
| 08/10/2023 | Additional vesting date for stock options. |
| 02/10/2025 | Date of the reported transactions (exercise of options and sale of shares). |
| 05/06/2025 | Expiration date of the 10b5-1 trading plan. |
| 02/27/2030 | Expiration date for some non-qualified stock options. |
| 08/09/2030 | Expiration date for some non-qualified stock options. |
Keywords
Form 4, Intuitive Surgical, ISRG, Jamie Samath, Stock Options, RSUs, 10b5-1 Plan, Executive Compensation, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.